Lexaria Bioscience (LEXX) Revenue & Revenue Breakdown
Lexaria Bioscience Revenue Highlights
Latest Revenue (Y)
$226.21K
Latest Revenue (Q)
$84.00K
Main Segment (Y)
License
Main Geography (Y)
License
Lexaria Bioscience Revenue by Period
Lexaria Bioscience Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-08-31 | $226.21K | -11.43% |
| 2022-08-31 | $255.40K | -64.66% |
| 2021-08-31 | $722.74K | 87.95% |
| 2020-08-31 | $384.54K | 72.74% |
| 2019-08-31 | $222.61K | -48.62% |
| 2018-08-31 | $433.29K | 580.85% |
| 2017-08-31 | $63.64K | 56.29% |
| 2016-08-31 | $40.72K | 176.96% |
| 2015-08-31 | $14.70K | -98.66% |
| 2014-08-31 | $1.10M | -19.17% |
| 2012-10-31 | $1.36M | 19.76% |
| 2011-10-31 | $1.13M | 212.79% |
| 2010-10-31 | $362.47K | -14.10% |
| 2009-10-31 | $421.95K | -53.16% |
| 2008-10-31 | $900.79K | 255.83% |
| 2007-10-31 | $253.15K | 1146.60% |
| 2006-10-31 | $20.31K | 100.00% |
| 2005-10-31 | - | - |
Lexaria Bioscience generated $226.21K in revenue during NA 2023, up -11.43% compared to the previous quarter, and up 52.21% compared to the same period a year ago.
Lexaria Bioscience Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-05-31 | $84.00K | -42.07% |
| 2024-02-29 | $145.00K | -4.15% |
| 2023-11-30 | $151.28K | -4506.58% |
| 2023-08-31 | $-3.43K | -103.69% |
| 2023-05-31 | $93.15K | 166.03% |
| 2023-02-28 | $35.02K | -65.49% |
| 2022-11-30 | $101.48K | -8.70% |
| 2022-08-31 | $111.15K | 11.47% |
| 2022-05-31 | $99.72K | 225.34% |
| 2022-02-28 | $30.65K | 120.82% |
| 2021-11-30 | $13.88K | -55.26% |
| 2021-08-31 | $31.02K | -84.80% |
| 2021-05-31 | $204.06K | 6.28% |
| 2021-02-28 | $192.01K | -35.06% |
| 2020-11-30 | $295.66K | 121.07% |
| 2020-08-31 | $133.74K | 64.25% |
| 2020-05-31 | $81.42K | -24.12% |
| 2020-02-29 | $107.30K | 72.83% |
| 2019-11-30 | $62.08K | -50.38% |
| 2019-08-31 | $125.12K | 108.78% |
| 2019-05-31 | $59.93K | 290.46% |
| 2019-02-28 | $15.35K | -30.89% |
| 2018-11-30 | $22.21K | -76.95% |
| 2018-08-31 | $96.35K | -31.34% |
| 2018-05-31 | $140.34K | -18.39% |
| 2018-02-28 | $171.96K | 598.02% |
| 2017-11-30 | $24.64K | 96.15% |
| 2017-08-31 | $12.56K | -57.07% |
| 2017-05-31 | $29.25K | 132.13% |
| 2017-02-28 | $12.60K | 36.61% |
| 2016-11-30 | $9.22K | 7.74% |
| 2016-08-31 | $8.56K | 37.76% |
| 2016-05-31 | $6.21K | -58.99% |
| 2016-02-29 | $15.15K | 227.16% |
| 2015-08-31 | $4.63K | -35.55% |
| 2015-05-31 | $7.19K | 149.29% |
| 2015-02-28 | $2.88K | 100.00% |
| 2014-11-30 | - | -100.00% |
| 2014-07-31 | $135.86K | -19.05% |
| 2014-04-30 | $167.84K | 4.83% |
| 2014-01-31 | $160.10K | -33.59% |
| 2013-10-31 | $241.09K | -4.13% |
| 2013-07-31 | $251.48K | -0.75% |
| 2013-04-30 | $253.39K | -27.91% |
| 2013-01-31 | $351.49K | -25.06% |
| 2012-10-31 | $469.04K | -5.15% |
| 2012-07-31 | $494.48K | 241.35% |
| 2012-04-30 | $144.86K | -41.91% |
| 2012-01-31 | $249.38K | 95.29% |
| 2011-10-31 | $127.70K | -64.49% |
| 2011-07-31 | $359.62K | 13.70% |
| 2011-04-30 | $316.28K | -4.20% |
| 2011-01-31 | $330.16K | 169.60% |
| 2010-07-31 | $122.46K | 203.67% |
| 2010-04-30 | $40.33K | -57.99% |
| 2009-10-31 | $95.99K | -25.90% |
| 2009-07-31 | $129.54K | 92.87% |
| 2009-04-30 | $67.17K | -48.04% |
| 2009-01-31 | $129.26K | 32.58% |
| 2008-10-31 | $97.50K | -58.08% |
| 2008-07-31 | $232.56K | 7.48% |
| 2008-04-30 | $216.39K | -38.93% |
| 2008-01-31 | $354.34K | 239.34% |
| 2007-10-31 | $104.42K | 18.67% |
| 2007-07-31 | $87.99K | 122.11% |
| 2007-04-30 | $39.61K | 100.00% |
| 2006-10-31 | - | 100.00% |
| 2006-07-31 | - | 100.00% |
| 2006-04-30 | - | - |
Lexaria Bioscience generated $84.00K in revenue during Q3 2024, up -42.07% compared to the previous quarter, and up 239.90% compared to the same period a year ago.
Lexaria Bioscience Revenue Breakdown
Lexaria Bioscience Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Aug 20 | Aug 19 | Aug 18 |
|---|---|---|---|
| License | $232.91K | $198.00K | $415.18K |
| Product | $121.91K | $24.28K | $16.97K |
| Freight revenuet | $641.00 | $328.00 | - |
| Cargo and Freight | - | - | $1.14K |
Lexaria Bioscience's latest annual revenue breakdown by segment (product or service), as of Aug 20: License (65.52%), Product (34.30%), and Freight revenuet (0.18%).
Quarterly Revenue by Product
| Product/Service | May 24 | Feb 24 | May 21 | Feb 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Feb 19 | Nov 18 | May 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | $900.00 | $900.00 | - | - | - | - | - | - | - | - | - | - | - | - |
| IP Licensing | $373.99K | $289.99K | - | - | - | - | - | - | - | - | - | - | - | - |
| Freight Revenue | - | - | - | $18.00 | $82.00 | - | - | - | - | - | - | - | - | - |
| Interest Revenue | - | - | $4.58K | - | - | - | - | - | - | - | - | - | - | - |
| License Revenue | - | - | $70.63K | - | - | - | - | - | - | - | - | - | - | - |
| Product Sales | - | - | $128.84K | - | - | - | - | - | - | - | - | - | - | - |
| License | - | - | - | $125.26K | $130.58K | $102.40K | $60.76K | $18.00K | $51.75K | $108.00K | $58.00K | $12.10K | $19.90K | - |
| Product | - | - | - | $66.73K | $164.99K | $31.28K | $20.52K | $89.18K | $10.02K | $17.00K | $1.85K | $3.18K | $2.26K | - |
| Freight revenuet | - | - | - | - | - | $55.00 | $146.00 | $123.00 | $317.00 | $123.00 | $83.00 | $122.00 | - | - |
| Cargo and Freight | - | - | - | - | - | - | - | - | - | - | - | - | $50.00 | - |
| Intellectual Property Licensing | - | - | - | - | - | - | - | - | - | - | - | - | - | $137.60K |
| Consumer Products | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.74K |
Lexaria Bioscience's latest quarterly revenue breakdown by segment (product or service), as of May 24: IP Licensing (99.76%), and Other (0.24%).
Lexaria Bioscience Revenue Breakdown by Country
Annual Revenue by Country
| Country | Aug 20 | Aug 19 | Aug 18 |
|---|---|---|---|
| Freight revenuet | $641.00 | $328.00 | - |
| Product | $121.91K | $24.28K | $16.97K |
| License | $232.91K | $198.00K | $415.18K |
| Cargo and Freight | - | - | $1.14K |
Lexaria Bioscience's latest annual revenue breakdown by geography, as of Aug 20: License (65.52%), Product (34.30%), and Freight revenuet (0.18%).
Quarterly Revenue by Country
| Country | May 21 | Feb 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Feb 19 | Nov 18 | May 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Revenue | $4.58K | - | - | - | - | - | - | - | - | - | - | - |
| Freight Revenue | - | $18.00 | $82.00 | - | - | - | - | - | - | - | - | - |
| Product Sales | $128.84K | - | - | - | - | - | - | - | - | - | - | - |
| License Revenue | $70.63K | - | - | - | - | - | - | - | - | - | - | - |
| Product | - | $66.73K | $164.99K | $31.28K | $20.52K | $89.18K | $10.02K | $17.00K | $1.85K | $3.18K | $2.26K | - |
| License | - | $125.26K | $130.58K | $102.40K | $60.76K | $18.00K | $51.75K | $108.00K | $58.00K | $12.10K | $19.90K | - |
| Freight revenuet | - | - | - | $55.00 | $146.00 | $123.00 | $317.00 | $123.00 | $83.00 | $122.00 | - | - |
| Cargo and Freight | - | - | - | - | - | - | - | - | - | - | $50.00 | - |
| Consumer Products | - | - | - | - | - | - | - | - | - | - | - | $2.74K |
| Intellectual Property Licensing | - | - | - | - | - | - | - | - | - | - | - | $137.60K |
Lexaria Bioscience's latest quarterly revenue breakdown by geography, as of May 21: Product Sales (63.14%), License Revenue (34.61%), and Interest Revenue (2.25%).
Lexaria Bioscience Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| LEXX | Lexaria Bioscience | $226.21K | $84.00K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| CNSP | CNS Pharmaceuticals | - | - |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| ICU | SeaStar Medical | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| IMMX | Immix Biopharma | - | - |
| ONCR | Oncorus | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| VIRI | Virios Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
LEXX Revenue FAQ
What is Lexaria Bioscience’s yearly revenue?
Lexaria Bioscience's yearly revenue for 2023 was $226.21K, representing a decrease of -11.43% compared to 2022. The company's yearly revenue for 2022 was $255.4K, representing a decrease of -64.66% compared to 2021. LEXX's yearly revenue for 2021 was $722.74K, representing an increase of 87.95% compared to 2020.
What is Lexaria Bioscience’s quarterly revenue?
Lexaria Bioscience's quarterly revenue for Q3 2024 was $84K, a -42.07% decrease from the previous quarter (Q2 2024), and a -9.82% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $145K, a -4.15% decrease from the previous quarter (Q1 2024), and a 314.11% increase year-over-year (Q2 2023). LEXX's quarterly revenue for Q1 2024 was $151.28K, a -4506.58% decrease from the previous quarter (Q4 2023), and a 49.08% increase year-over-year (Q1 2023).
What is Lexaria Bioscience’s revenue growth rate?
Lexaria Bioscience's revenue growth rate for the last 3 years (2021-2023) was -68.70%, and for the last 5 years (2019-2023) was 1.62%.
What are Lexaria Bioscience’s revenue streams?
Lexaria Bioscience's revenue streams in g 20 are License, Product, and Freight revenuet. License generated $232.91K in revenue, accounting 65.52% of the company's total revenue, up 17.63% year-over-year. Product generated $121.91K in revenue, accounting 34.30% of the company's total revenue, up 402.04% year-over-year. Freight revenuet generated $641 in revenue, accounting 0.18% of the company's total revenue, up 95.43% year-over-year.
What is Lexaria Bioscience’s main source of revenue?
For the fiscal year ending Aug 20, the largest source of revenue of Lexaria Bioscience was License. This segment made a revenue of $232.91K, representing 65.52% of the company's total revenue.